2023 Q3 Form 10-Q Financial Statement

#000078332423000050 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $666.0K $878.0K
YoY Change -14.51% 0.23%
% of Gross Profit
Research & Development $848.0K $682.0K
YoY Change -7.42% -30.69%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $1.524M $1.570M
YoY Change -10.62% -16.04%
Operating Profit
YoY Change
Interest Expense $68.00K $70.00K
YoY Change 83.78% 677.78%
% of Operating Profit
Other Income/Expense, Net $70.00K $67.00K
YoY Change 438.46% -84.98%
Pretax Income -$1.454M -$1.503M
YoY Change -14.07% 5.55%
Income Tax
% Of Pretax Income
Net Earnings -$1.454M -$1.503M
YoY Change -14.07% 5.55%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 121.1M 119.8M
Diluted Shares Outstanding 121.1M 120.6M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.848M $5.986M
YoY Change -49.39% -45.93%
Cash & Equivalents $4.848M $5.986M
Short-Term Investments
Other Short-Term Assets $283.0K $342.0K
YoY Change 33.49% -18.76%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.131M $6.328M
YoY Change -47.6% -44.93%
LONG-TERM ASSETS
Property, Plant & Equipment $206.0K $173.0K
YoY Change 0.98% -19.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.352M $2.319M
YoY Change 0.09% -1.9%
TOTAL ASSETS
Total Short-Term Assets $5.131M $6.328M
Total Long-Term Assets $2.352M $2.319M
Total Assets $7.483M $8.647M
YoY Change -38.37% -37.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $156.0K $55.00K
YoY Change 1.3% -73.68%
Accrued Expenses $788.0K $703.0K
YoY Change 6.63% -13.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $944.0K $758.0K
YoY Change 5.71% -26.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $39.00K $36.00K
YoY Change 34.48% 33.33%
Total Long-Term Liabilities $39.00K $36.00K
YoY Change 34.48% 33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $944.0K $758.0K
Total Long-Term Liabilities $39.00K $36.00K
Total Liabilities $983.0K $794.0K
YoY Change 6.62% -24.6%
SHAREHOLDERS EQUITY
Retained Earnings -$469.7M -$468.3M
YoY Change 1.39% 1.44%
Common Stock $476.2M $476.1M
YoY Change 0.36% 0.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.500M $7.853M
YoY Change
Total Liabilities & Shareholders Equity $7.483M $8.647M
YoY Change -38.37% -37.59%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.454M -$1.503M
YoY Change -14.07% 5.55%
Depreciation, Depletion And Amortization $10.00K $10.00K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$1.095M -$1.219M
YoY Change -26.9% -32.28%
INVESTING ACTIVITIES
Capital Expenditures $43.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$43.00K $0.00
YoY Change -111.2% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 560.0K
YoY Change -100.0% 2334.78%
NET CHANGE
Cash From Operating Activities -1.095M -1.219M
Cash From Investing Activities -43.00K 0.000
Cash From Financing Activities 0.000 560.0K
Net Change In Cash -1.138M -659.0K
YoY Change 1.97% -63.14%
FREE CASH FLOW
Cash From Operating Activities -$1.095M -$1.219M
Capital Expenditures $43.00K $0.00
Free Cash Flow -$1.138M -$1.219M
YoY Change -24.03% -32.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0000783324
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-09025
dei Entity Registrant Name
EntityRegistrantName
VISTA GOLD CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0542444
dei Entity Address Address Line1
EntityAddressAddressLine1
8310 S Valley Hwy, Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
981-1185
dei Security12b Title
Security12bTitle
Common Shares, no par value
dei Trading Symbol
TradingSymbol
VGZ
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121088494
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5986000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8110000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
342000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
537000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
6328000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8647000
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
2146000
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
2146000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193000
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2319000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2339000
CY2023Q2 us-gaap Assets
Assets
8647000
CY2022Q4 us-gaap Assets
Assets
10986000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
55000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
169000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
703000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
764000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
758000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
933000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
36000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
24000
CY2023Q2 us-gaap Liabilities
Liabilities
794000
CY2022Q4 us-gaap Liabilities
Liabilities
957000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121088494
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
118480878
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
476145000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
474847000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-468292000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-464818000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7853000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10029000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8647000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10986000
vgz Gain Loss On Disposal Of Mineral Property Interests Net
GainLossOnDisposalOfMineralPropertyInterestsNet
2883000
CY2023Q2 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
682000
CY2022Q2 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
984000
us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
1486000
us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
2773000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
878000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
876000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2046000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2277000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1570000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1870000
us-gaap Operating Expenses
OperatingExpenses
3552000
us-gaap Operating Expenses
OperatingExpenses
2191000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
70000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000
us-gaap Investment Income Interest
InvestmentIncomeInterest
139000
us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
437000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
437000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
67000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
446000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
78000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
447000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1503000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1424000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3474000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1744000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1503000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1424000
us-gaap Net Income Loss
NetIncomeLoss
-3474000
us-gaap Net Income Loss
NetIncomeLoss
-1744000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120637683
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118080896
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119843910
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117764401
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120637683
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118080896
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119843910
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117764401
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
14091000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-28000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
112000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1424000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12802000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8548000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
560000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
248000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1503000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7853000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14294000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-355000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
556000
us-gaap Net Income Loss
NetIncomeLoss
-1744000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12802000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10029000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1013000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-142000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
427000
us-gaap Net Income Loss
NetIncomeLoss
-3474000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7853000
us-gaap Profit Loss
ProfitLoss
-3474000
us-gaap Profit Loss
ProfitLoss
-1744000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24000
us-gaap Share Based Compensation
ShareBasedCompensation
427000
us-gaap Share Based Compensation
ShareBasedCompensation
556000
vgz Gain Loss On Disposal Of Mineral Property Interests Net
GainLossOnDisposalOfMineralPropertyInterestsNet
2883000
us-gaap Other Increase Decrease In Environmental Liabilities
OtherIncreaseDecreaseInEnvironmentalLiabilities
-240000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-195000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-400000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-163000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-365000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2995000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4252000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
2500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2495000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1013000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
51000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
142000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
355000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
871000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-304000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2124000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2061000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8110000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12757000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5986000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10696000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5697000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5524000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5697000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5504000
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
130000
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
112000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
532000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
614000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
41000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
703000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
764000
vgz Percentage Of Issued And Outstanding Common Shares For Stock Based Compensation Plan
PercentageOfIssuedAndOutstandingCommonSharesForStockBasedCompensationPlan
0.10
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
248000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
112000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
427000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
556000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1367000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y7M20D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
38000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1367000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7M20D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
700000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.75
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
667000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7M20D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
667000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y7M20D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0

Files In Submission

Name View Source Status
0000783324-23-000050-index-headers.html Edgar Link pending
0000783324-23-000050-index.html Edgar Link pending
0000783324-23-000050.txt Edgar Link pending
0000783324-23-000050-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vgz-20230630.xsd Edgar Link pending
vgz-20230630x10q.htm Edgar Link pending
vgz-20230630x10q001.jpg Edgar Link pending
vgz-20230630xex23d1.htm Edgar Link pending
vgz-20230630xex23d2.htm Edgar Link pending
vgz-20230630xex23d3.htm Edgar Link pending
vgz-20230630xex23d4.htm Edgar Link pending
vgz-20230630xex31d1.htm Edgar Link pending
vgz-20230630xex31d2.htm Edgar Link pending
vgz-20230630x10q_htm.xml Edgar Link completed
vgz-20230630xex32d1.htm Edgar Link pending
vgz-20230630xex32d2.htm Edgar Link pending
vgz-20230630_lab.xml Edgar Link unprocessable
vgz-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
vgz-20230630_cal.xml Edgar Link unprocessable
vgz-20230630_def.xml Edgar Link unprocessable